DUBLIN--(BUSINESS WIRE)--The "Post-Operative Pain Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.
Post-Operative Pain Pipeline Highlights - 2017 Update, provides the most up-to-date information on key pipeline products in the global Post-Operative Pain market.
It covers emerging therapies for post-operative pain in active clinical development stages, including early and late stage clinical trials. The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides post-operative pain pipeline products by clinical trial stages, including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides post-operative pain pipeline products by their dominant mechanism of action. This helps executives to categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides post-operative pain pipeline products by the company.
Short-term Launch Highlights:
Find out which post-operative pain pipeline products will be launched in the US and ex-US to 2020.
- Post-Operative Pain phase 3 clinical trial pipeline products
- Post-Operative Pain phase 2 clinical trial pipeline products
- Post-Operative Pain phase 1 clinical trial pipeline products
- Post-Operative Pain preclinical research pipeline products
- Post-Operative Pain discovery stage pipeline products
- Post-Operative Pain pipeline products short-term launch highlights
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/pg2gpc/postoperative?w=4